| Protein production and purification Architecture et Fonction des Macromolécules Biologiques Vincentelli Renaud 4 ... Nature methods 5 (2), 135-146, 2008 | 944* | 2008 |
| A versatile ligation-independent cloning method suitable for high-throughput expression screening applications NS Berrow, D Alderton, S Sainsbury, J Nettleship, R Assenberg, ... Nucleic acids research 35 (6), e45, 2007 | 600 | 2007 |
| Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease NR West, AN Hegazy, BMJ Owens, SJ Bullers, B Linggi, S Buonocore, ... Nature medicine 23 (5), 579-589, 2017 | 564 | 2017 |
| Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ... Nature structural & molecular biology 27 (9), 846-854, 2020 | 427 | 2020 |
| Structure and functionality in flavivirus NS-proteins: perspectives for drug design M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard, S Cook, ... Antiviral research 87 (2), 125-148, 2010 | 402 | 2010 |
| Lysine methylation as a routine rescue strategy for protein crystallization TS Walter, C Meier, R Assenberg, KF Au, J Ren, A Verma, JE Nettleship, ... Structure 14 (11), 1617-1622, 2006 | 352 | 2006 |
| Neutralization of SARS-CoV-2 by destruction of the prefusion spike J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ... Cell host & microbe 28 (3), 445-454. e6, 2020 | 322 | 2020 |
| Glycoprotein structural genomics: solving the glycosylation problem VT Chang, M Crispin, AR Aricescu, DJ Harvey, JE Nettleship, JA Fennelly, ... Structure 15 (3), 267-273, 2007 | 318 | 2007 |
| CDR grafted anti-CEA antibodies and their production JR Adair, MW Bodmer, A Mountain, RJ Owens US Patent 5,877,293, 1999 | 280 | 1999 |
| The nsp9 replicase protein of SARS-coronavirus, structure and functional insights G Sutton, E Fry, L Carter, S Sainsbury, T Walter, J Nettleship, N Berrow, ... Structure 12 (2), 341-353, 2004 | 276 | 2004 |
| A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization TS Walter, JM Diprose, CJ Mayo, C Siebold, MG Pickford, L Carter, ... Acta Crystallographica Section D: Biological Crystallography 61 (6), 651-657, 2005 | 269 | 2005 |
| Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient D Zhou, HME Duyvesteyn, CP Chen, CG Huang, TH Chen, SR Shih, ... Nature structural & molecular biology 27 (10), 950-958, 2020 | 256 | 2020 |
| The crystal structure of IgE Fc reveals an asymmetrically bent conformation T Wan, RL Beavil, SM Fabiane, AJ Beavil, MK Sohi, M Keown, RJ Young, ... Nature immunology 3 (7), 681-686, 2002 | 201 | 2002 |
| Recombinant protein expression and solubility screening in Escherichia coli: a comparative study NS Berrow, K Büssow, B Coutard, J Diprose, M Ekberg, GE Folkers, ... Acta Crystallographica Section D: Biological Crystallography 62 (10), 1218-1226, 2006 | 199 | 2006 |
| Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications C Tiede, AAS Tang, SE Deacon, U Mandal, JE Nettleship, RL Owen, ... Protein Engineering, Design and Selection 27 (5), 145-155, 2014 | 188 | 2014 |
| A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses TK Tan, P Rijal, R Rahikainen, AH Keeble, L Schimanski, S Hussain, ... Nature communications 12 (1), 542, 2021 | 185 | 2021 |
| Primary structure of the human, membrane‐associated Ca2+‐binding protein p68 a novel member of a protein family. MR Crompton, RJ Owens, NF Totty, SE Moss, MD Waterfield, ... The EMBO journal 7 (1), 21-27, 1988 | 184 | 1988 |
| Structural and functional insights of RANKL–RANK interaction and signaling C Liu, TS Walter, P Huang, S Zhang, X Zhu, Y Wu, LR Wedderburn, ... The Journal of Immunology 184 (12), 6910-6919, 2010 | 176 | 2010 |
| Vaccinia virus proteins A52 and B14 share a Bcl-2–like fold but have evolved to inhibit NF-κB rather than apoptosis SC Graham, MW Bahar, S Cooray, RAJ Chen, DM Whalen, NGA Abrescia, ... PLoS pathogens 4 (8), e1000128, 2008 | 174 | 2008 |
| Affimer proteins are versatile and renewable affinity reagents C Tiede, R Bedford, SJ Heseltine, G Smith, I Wijetunga, R Ross, ... Elife 6, e24903, 2017 | 170 | 2017 |
